Early in the pandemic, the term "herd immunity" hit the headlines, along with a polarized discussion on how to achieve it.
Jun 3, 2022
0
8
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Dec 3, 2012
0
1
A multi-institutional study, as reported in the journal Infection Control and Hospital Epidemiology, shows that mandatory flu vaccines for healthcare workers improve vaccination rates by as much as 30 percent and reduce absenteeism ...
Mar 9, 2018
0
9
Hundreds of thousands of people in China were in lockdown on Friday as the country battled its worst COVID-19 outbreak in months, while Japan—a week into the Olympics—extended its state of emergency due to surging infections.
Jul 30, 2021
0
325
It is too early to call for a second COVID-19 booster shot, Europe's medicines watchdog said Thursday, despite a rapid spike in new infections caused by the rampant Omicron variant.
Mar 17, 2022
0
2
There were over 600,000 new cases of cervical cancer and over 340,000 deaths worldwide in 2020, according to an observational study published in The Lancet Global Health journal.
Dec 14, 2022
0
18
Researchers said Monday they were a step closer to developing a vaccine against the type of meningitis that mostly affects Europe and North America and kills hundreds every year.
May 7, 2012
0
0
Vaccine hesitancy is just one reason fewer people in some parts of the United States have been inoculated against coronavirus.
Dec 15, 2022
0
68
A comprehensive review of vaccine data over a 20-year period finds that vaccines are remarkably safe.
Jul 28, 2020
0
18
"You don't count your children until the measles has passed." Dr. Samuel Katz, one of the pioneers of the first measles vaccine in the late 1950s to early 1960s, regularly heard this tragic statement from parents in countries ...
Mar 3, 2024
0
39
